DYRK1A Gene: History
Please note this is an old version of this entry, which may differ significantly from the current revision.

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A

  • genes

1. Normal Function

The DYRK1A gene provides instructions for making an enzyme that is important in the development of the nervous system. The DYRK1A enzyme is a kinase, which means that it adds a cluster of oxygen and phosphorus atoms (a phosphate group) to other proteins through a process called phosphorylation. Phosphorylation of proteins helps to control (regulate) their activity.

The proteins whose activity the DYRK1A enzyme helps regulate are involved in various processes in cells, including cell growth and division (proliferation) and the process by which cells mature to carry out specific functions (differentiation). In nerve cells (neurons), the DYRK1A enzyme is involved in the formation and maturation of dendritic spines from dendrites. Dendrites are specialized extensions from neurons that are essential for the transmission of nerve impulses. Dendritic spines are small outgrowths from dendrites that further help transmit nerve impulses and increase communication between neurons.

2. Health Conditions Related to Genetic Changes

2.1 Autism Spectrum Disorder

At least 11 DYRK1A gene mutations have been identified in people with autism spectrum disorder (ASD), a varied condition characterized by impaired social skills, communication problems, and repetitive behaviors. Most people with ASD associated with DYRK1A gene mutations also have other signs and symptoms. In some cases, they have a particular combination of additional features, including intellectual disability, speech problems, anxiety, and an unusually small head (microcephaly). Other signs and symptoms that may occur in these individuals include recurrent seizures (epilepsy), characteristic facial features, weak muscle tone (hypotonia), foot abnormalities, and walking problems (gait disturbance). This pattern of signs and symptoms is sometimes called DYRK1A-related intellectual disability syndrome.

DYRK1A gene mutations result in loss of the DYRK1A enzyme or an enzyme that does not function properly. Impaired or absent DYRK1A enzyme function likely leads to abnormal regulation of gene expression and disrupts proper neural development. However, the specific relationship between DYRK1A gene mutations and the signs and symptoms of ASD, as well as the other features that may occur in people with these mutations, is unclear.

3. Other Names for This Gene

  • dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1A

  • dual specificity YAK1-related kinase

  • DYRK

  • DYRK1

  • HP86

  • MNB

  • mnb protein kinase homolog hp86

  • MNB/DYRK protein kinase

  • MNBH

  • MRD7

  • protein kinase minibrain homolog

  • serine/threonine kinase MNB

  • serine/threonine-specific protein kinase

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/dyrk1a


  1. Bronicki LM, Redin C, Drunat S, Piton A, Lyons M, Passemard S, Baumann C,Faivre L, Thevenon J, Rivière JB, Isidor B, Gan G, Francannet C, Willems M, GunelM, Jones JR, Gleeson JG, Mandel JL, Stevenson RE, Friez MJ, Aylsworth AS. Ten newcases further delineate the syndromic intellectual disability phenotype caused bymutations in DYRK1A. Eur J Hum Genet. 2015 Nov;23(11):1482-7. doi:10.1038/ejhg.2015.29.
  2. Dang T, Duan WY, Yu B, Tong DL, Cheng C, Zhang YF, Wu W, Ye K, Zhang WX, Wu M,Wu BB, An Y, Qiu ZL, Wu BL. Autism-associated Dyrk1a truncation mutants impairneuronal dendritic and spine growth and interfere with postnatal corticaldevelopment. Mol Psychiatry. 2018 Mar;23(3):747-758. doi: 10.1038/mp.2016.253.
  3. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, LeeYH, Narzisi G, Leotta A, Kendall J, Grabowska E, Ma B, Marks S, Rodgers L,Stepansky A, Troge J, Andrews P, Bekritsky M, Pradhan K, Ghiban E, Kramer M,Parla J, Demeter R, Fulton LL, Fulton RS, Magrini VJ, Ye K, Darnell JC, DarnellRB, Mardis ER, Wilson RK, Schatz MC, McCombie WR, Wigler M. De novo genedisruptions in children on the autistic spectrum. Neuron. 2012 Apr26;74(2):285-99. doi: 10.1016/j.neuron.2012.04.009.
  4. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, Carvill G,Kumar A, Lee C, Ankenman K, Munson J, Hiatt JB, Turner EH, Levy R, O'Day DR,Krumm N, Coe BP, Martin BK, Borenstein E, Nickerson DA, Mefford HC, Doherty D,Akey JM, Bernier R, Eichler EE, Shendure J. Multiplex targeted sequencingidentifies recurrently mutated genes in autism spectrum disorders. Science. 2012 Dec 21;338(6114):1619-22. doi: 10.1126/science.1227764.
  5. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, LeeC, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, AkeyJM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE.Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012 Apr 4;485(7397):246-50. doi: 10.1038/nature10989.
  6. van Bon BW, Coe BP, Bernier R, Green C, Gerdts J, Witherspoon K, Kleefstra T, Willemsen MH, Kumar R, Bosco P, Fichera M, Li D, Amaral D, Cristofoli F, Peeters H, Haan E, Romano C, Mefford HC, Scheffer I, Gecz J, de Vries BB, Eichler EE.Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.Mol Psychiatry. 2016 Jan;21(1):126-32. doi: 10.1038/mp.2015.5.
  7. Wang T, Guo H, Xiong B, Stessman HA, Wu H, Coe BP, Turner TN, Liu Y, Zhao W,Hoekzema K, Vives L, Xia L, Tang M, Ou J, Chen B, Shen Y, Xun G, Long M, Lin J,Kronenberg ZN, Peng Y, Bai T, Li H, Ke X, Hu Z, Zhao J, Zou X, Xia K, Eichler EE.De novo genic mutations among a Chinese autism spectrum disorder cohort. NatCommun. 2016 Nov 8;7:13316. doi: 10.1038/ncomms13316.
This entry is offline, you can click here to edit this entry!
Video Production Service